NCT04044976View on ClinicalTrials.gov

Caffeine Treatment in in the Delivery Room

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

August 31, 2021

Conditions
Respiratory Distress Syndrome
Interventions
DRUG

Caffeine Citrate

Infants will receive 20 mg/kg of caffeine citrate intravenously, via the umbilical vein, or enterally, through an orogastric tube, within 10 min of birth.

Trial Locations (1)

50134

Division of Neonatology, Careggi University Hospital, Florence

All Listed Sponsors
lead

University of Florence

OTHER

NCT04044976 - Caffeine Treatment in in the Delivery Room | Biotech Hunter | Biotech Hunter